Showing results (211-220 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|May 31, 2019
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRTMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, William E Gooding, et al.
Oncoimmunology|May 31, 2019
A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune systemAude Burlion, Rodrigo N Ramos, Pukar Kc, et al.
Oncoimmunology|May 31, 2019
Neo-antigen specific memory T-cell responses in healthy individualsMorten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald Andersen
Oncoimmunology|October 29, 2021
Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancerZe-Rui Zhao, Chao-Pin Yang, Si Chen, et al.
Oncoimmunology|October 1, 2021
Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapyDuo Yang, Xiaoli Wang, Xinna Zhou, et al.
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Oncoimmunology|July 21, 2022
Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and immunogenic cell death in esophageal squamous cell carcinomaHui Luo, Xiaohui Wang, Shuai Song, et al.
Oncoimmunology|May 2, 2022
Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockadeG Kofla, C Radecke, M Frentsch, et al.
Oncoimmunology|February 14, 2022
T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG miceOlmo Sonzogni, Daniel E Zak, Maria Stella Sasso, et al.
Oncoimmunology|February 14, 2022
Antibody-drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory propertiesAnette Sommer, Sandra Berndt, Hans-Georg Lerchen, et al.
Pageof 379